Revivn Public Benefit Corporation – Trademark Portfolio
Entity Type: 99
Revivn Public Benefit Corporation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REVIVN and OMAHA BLUE. The owner is based in Brooklyn, NY.
141 Flushing Ave, Suite 601
Brooklyn, NY 11205
Showing of trademarks Trademarks
Trademark Classifications
Revivn Public Benefit Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Revivn Public Benefit Corporation have?
Revivn Public Benefit Corporation has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Revivn Public Benefit Corporation file in?
Revivn Public Benefit Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 35 covers advertising; business management; business administration; office functions.
What are Revivn Public Benefit Corporation's most well-known trademarks?
Revivn Public Benefit Corporation's registered trademark portfolio includes well-known marks such as REVIVN and OMAHA BLUE. These are among 2 currently registered trademarks in the portfolio.
What is Revivn Public Benefit Corporation's trademark registration success rate?
Revivn Public Benefit Corporation has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.